Pharmaceutics, 2022 Varicella zoster virus (VZV) causes two diseases: varicella upon primary infection and herpes zoster when latent viruses in the sensory ganglia reactivate.
Ning Luan +4 more
doaj +1 more source
Uveitis reactivation following recombinant zoster vaccination
American Journal of Ophthalmology Case Reports, 2021 Purpose: Describe three cases of uveitis reactivation following immunization with recombinant zoster vaccine (RZV). Observations: One patient developed reactivation of previously controlled multifocal choroiditis within one week of receiving RZV ...
Paige J. Richards +3 more
doaj +1 more source
Acute retinal necrosis following recombinant subunit varicella-zoster virus vaccine. [PDF]
, 2020 PURPOSE: Previously, secondary prevention of herpes zoster required live-attenuated vaccination, which is contraindicated in immunocompromised populations.
Chen, Rebecca +3 more
core +1 more source
Ocular effects caused by viral infections and corresponding vaccines: An overview of varicella zoster virus, measles virus, influenza viruses, hepatitis B viruses, and SARS-CoV-2 [PDF]
, 2022 Many viral infections can affect vision and the visual system. Vaccination to prevent diseases is commonplace today, acting by stimulating an immune response without developing the pathology.
Becco, A. +3 more
core +1 more source
Identification and Characterization of CD4 + T Cell Epitopes after Shingrix Vaccination [PDF]
Journal of Virology, 2020 Understanding the T cell profile associated with the protection observed in elderly vaccinees following Shingrix vaccination is relevant to the general definition of correlates of vaccine efficacy. Our study enables these future studies by clarifying the patterns of immunodominance associated with Shingrix vaccination, as opposed to natural infection ...
Hannah Voic +10 more
openaire +4 more sources
Bullous fixed drug eruption following administration of the recombinant adjuvant Shingrix vaccine [PDF]
BMJ Case Reports, 2021 A 51-year-old woman with Crohn’s disease presented with a bullous rash on her left arm and axilla 2 days after receiving her second dose of the recombinant adjuvant Shingrix vaccine. PCR for herpes simplex virus (HSV) 1, HSV 2 and varicella zoster virus was negative. Punch biopsy revealed changes that were consistent with a bullous fixed drug eruption.
Thompson, Hallie +2 more
openaire +2 more sources
Vaccines, 2022 Increasing numbers of patients with zoster were reported recently, and recombinant zoster vaccine (Shingrix®) was licensed using the AS01B adjuvant system.
Tetsuo Nakayama +2 more
doaj +1 more source
A Patient-Facing Dashboard to Promote Shingrix™ Vaccination in a Continuing Care Retirement Community: A Quality Improvement Project [PDF]
, 2021 BACKGROUND: Shingles is considered one of the most significant vaccine-preventable diseases of older adults based on its morbidity and public health burden, which increase drastically with age.
Stewart, Emily S
core +1 more source
Surveying a Sample of the Spanish Ophthalmologic Community about Vaccination against Herpes Zoster [PDF]
, 2023 There are currently two authorized vaccines against herpes zoster (HZ) that have been shown to be safe and effective in its prevention: Zostavax, a zoster vaccine live (ZVL), and Shingrix, a recombinant zoster Vaccine (RZV). Because ophthalmologists work
Alcaraz Clemente, Luis +5 more
core +1 more source
Antisynthetase Syndrome Post Shingrix and Pneumovax Vaccinations, Possible Correlation
Cureus, 2022 This is a case report of a patient who developed acute progressive shortness of breath that started two days following the administration of Shingrix and Pneumovax vaccinations. Eight days after the onset of his symptoms he was diagnosed with acute interstitial pneumonitis based on CT scan of the chest which later appeared to be consistent with the ...
Osman, Alsayed +3 more
openaire +2 more sources